Every year, an estimated 180 000 babies in the Western Pacific Region are infected by hepatitis B, 13 000 by syphilis and 1400 by HIV through mother-to-child transmission.
1 These infections can be largely prevented by antenatal screening, treatment and timely vaccination for newborns. Despite challenges in controlling each disease, major achievements have been made. National immunization programmes have reduced the regional hepatitis B prevalence from over 8% in 1990 to 0.93% among children born in 2012. In addition, HIV testing and treatment have helped keep the regional prevalence of HIV infections at 0.1%. In contrast, the number of maternal syphilis cases is still high in the Western Pacific Region, with an estimated 45 million cases in 2012. Elimination of mother-to-child transmission of these infections cannot be achieved through vertically applied programming and require using and augmenting to the shared Maternal, Newborn and Child Health platform to coordinate, integrate and enable cost efficiencies for these elimination efforts. 
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These three diseases have a significant burden in the Western Pacific Region: the Region alone accounts for 45% of all global hepatitis B infections;
2 an increasing trend of syphilis infections is observed among key populations including women of reproductive age; 6 and while HIV prevalence is low throughout the Region at 0.1%, the HIV mother-to-child transmission (MTCT) rate is high at 12%. Woodring et al Triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis Triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis Woodring et al The Triple Elimination Framework suggests a set of key indicators under the headings of policy, impact and programme for monitoring and evaluating EMTCT. This includes eventually developing global guidance that incorporates hepatitis B into WHO established criteria for EMTCT of HIV and syphilis. The Triple Elimination Framework will also need to be supplemented by an economic analysis of the introduction of additional interventions for EMTCT of hepatitis B. This is particularly pertinent for countries with high hepatitis B vaccine birth-dose and third-dose coverage rates that are looking to expand their perinatal programmes.
Moving towards triple elimination should result in greater collaboration between programmes and thus improve accessibility, effectiveness, efficiency and sustainability of MNCH services for every woman, child and their family. programmes for better health outcomes for mother and child.
1
Current interventions must be scaled up substantially, other interventions introduced and coordination among programmes improved to achieve the global EMTCT targets.
1, 13 In response, the Triple Elimination Framework proposes a vision to provide every child the greatest chance to start a healthy life free of three preventable communicable diseases. By better coordinating service delivery among programmes and including the incorporation of hepatitis B screening into existing HIV and syphilis screening at antenatal clinic, the Triple Elimination Framework looks to integrate these programmes to enable pregnant women to know their own and their partners' infection status. It also allows pregnant mothers to understand and receive the necessary interventions for themselves and their baby during pregnancy, delivery and postnatally and to ensure that their babies receive these necessary interventions to prevent transmission of these infections (Fig. 2) . 
16
Hepatitis B birth-dose vaccination has been promoted through EENC coaching to health workers dealing with intrapartum and postnatal care.
17 Fig. 1 shows that hepatitis B birth-dose coverage was higher than syphilis and HIV antenatal screening coverage in seven of eight countries, with China having 100% coverage for all three. This shows that coordination among the different programmes can improve access to essential services for both women and their babies, while lack of collaboration could result in limited access and inefficiencies.
Some countries in the Region have already begun pioneering a coordinated approach to triple elimination. For example, China has an EMTCT strategy that integrates provision of the essential package of services for universal HIV, hepatitis B and syphilis screening where all three tests are offered concurrently and free of charge. Further interventions such as HIV and syphilis treatment, including hepatitis B prophylaxis and follow-up testing and care for mothers and their children are provided for free. As a result, MTCT of HIV decreased to 6.7% in 2013, and over 1200 paediatric HIV infections were averted in 2014.
18 Mongolia has developed national guidelines for HIV, syphilis and hepatitis B and C antenatal screening, recommending antiviral treatment of women with high viral loads and hepatitis B immunoglobulin to infants born to these mothers. These underpin the importance of coordination and collaboration among concerned MNCH care has made significant progress in the Region. From 1990 through 2015, the maternal mortality ratio decreased by 64% from 114 to 41 maternal deaths per 100 000 live births, 8 in part due to the increases in antenatal care coverage and births attended by skilled birth attendants. Nearly nine in 10 pregnant women in the Region have attended at least one antenatal care visit and have delivered in a health facility, while provision of quality services and access to at least four antenatal visits still remain as challenges. 9 DTP3 vaccine coverage for children has remained over 95% since 2009 with 97.3% coverage in 2016. 10 These multiple entry points in receiving peripartum services provide a unique opportunity for coordination and integration of HIV, hepatitis B and syphilis interventions to move towards elimination of mother-to-child transmission (EMTCT) of these infections.
The Region has shown remarkable progress with national immunization programmes, reducing the regional HBsAg prevalence to less than 1% among children born in 2012. Not all countries met the 2012 or 2017 regional prevalence targets among 5-year-olds (less than 2% and less than 1%, respectively) or the regional 2017 milestones of 95% or higher hepatitis B birth dose and 95% or higher hepatitis B third-dose vaccine coverage.
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Thirty countries had evidence of meeting the 2012 goal of less than 2%; as of November 2017, 18 countries have been verified as meeting the 2017 goal of less than 1%, with five additional countries having evidence of meeting this same goal. Introduction of additional interventions are likely to be required to reach the 0.1% HBsAg prevalence elimination target by 2030, including antenatal HBsAg screening, antiviral treatment of pregnant women with high viral loads and the use of hepatitis B immunoglobulin among infants born to HBsAg-positive mothers. 4 Modelling has shown that global elimination of hepatitis B as a major public health threat can only be achieved by scaling up hepatitis B vaccine third-dose coverage to 90% and birth-dose coverage to 80%, peripartum antivirals to 80% of hepatitis B e-antigen-positive mothers and increasing testing and treatment to 80% of those eligible. 13 To meet these suggested screening and treatment targets, immunizations programmes must work with MNCH and sexually transmitted infection programmes through an integrated effort to reach hepatitis B EMTCT.
In 2014, WHO established the global criteria for dual EMTCT of HIV and syphilis that were further up- Woodring et al Triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis Triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis Woodring et al
